With WAYFIND-R, advancing precision oncology is within reach
WAYFIND-R is a global registry that will collect data from patients who have been diagnosed with a solid tumour and whose tumour has been profiled with a next-generation sequencing (NGS) test.
WAYFIND-R aims to enable collaborations and to provide meaningful insights and high-quality evidence to enhance our understanding of precision oncology and ultimately transform the lives of people with cancer.
Learn more about WAYFIND-R
WAYFIND-R is a global, multicentre, prospective pan-cancer registry to collect long-term data to gain clinical insights on characteristics and outcomes from patients with solid tumors profiled with a next-generation sequencing (NGS) test in routine care.
Explore data and research opportunities
WAYFIND-R aims to provide the medical and scientific community with access to high-quality data and exciting opportunities to collaborate and help advance cancer research, all within a secure database.
Become a participating site
WAYFIND-R is always looking to expand its community and work with new sites. The more sites that join, the more representative the WAYFIND-R population becomes. This will improve the quality and relevance of WAYFIND-R’s data and, in addition, its research capabilities and value for patients.